TOVX - Theriva Biologics, Inc.
0.381
0.008 2.073%
Share volume: 11,283,784
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.37
0.01
0.02%
Summary score
42%
Profitability
35%
Dept financing
33%
Liquidity
49%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-17.12%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
57.45%
Debt ratio change over timeo
0%
Current Ratio
1.7%
Quick Ratio
0%
Cash Position Ratio
1.33%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-17.52%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
65.02%
Debt ratio change over timeo
0%
Current Ratio
1.34%
Quick Ratio
0%
Cash Position Ratio
1.05%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-5.41%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
59.77%
Debt ratio change over time
0%
Current Ratio
1.74%
Quick Ratio
0%
Cash Position Ratio
1.3%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TOVX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -17.12% | 4.74% | 3.19% | 1.73% |
| Return on sales | 0% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 57.45% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | 0% | -20.57% | -85.61% | 17.33% |
| Dept financing | 15% | 21% | 16% | 50% |
| Current Ratio | 1.34% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.05% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 46% | 51% | 35% |
| Short-term ratios | TOVX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -17.52% | 6.06% | 4.18% | 1.7% |
| Return on sales | 0% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 23% |
| Total debt ratio | 65.02% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 41% | 20% | 15% | 25% |
| Current Ratio | 1.34% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.05% | 0.16% | 0.44% | 0.14% |
| Liquididy | 48% | 54% | 48% | 29% |